Recent Company News

• 05:30 PM ET Oct 31, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 08:45 AM ET Sep 18, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:03 AM ET Oct 20, 2025
  

  BeOne Medicines presents new data on TEVIMBRA in lung cancer at ESMO 2025, early findings on BGB-26808 ($316.42, 0.00)

• 06:02 AM ET Oct 13, 2025
  

  BeOne Medicines Sonrotoclax granted Breakthrough Therapy Designation by U.S. FDA ($320.10, 0.00)

• 03:23 AM ET Oct 06, 2025
  

  StreetAccount Sector Summary - China Healthcare September Recap

• 10:03 AM ET Oct 02, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (217 total)

• 05:20 AM ET Oct 02, 2025
  

  Pharmacyclics decides not to appeal USPTO's final written decision on claims of Pharmacyclics's '803 patent ($335.16, 0.00)

• 05:33 AM ET Sep 30, 2025
  

  BeOne Medicines initiated buy at China Post Securities (timing uncertain) (CNY 306.90, 0.00)

• 04:39 PM ET Sep 18, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market